Social Responsiveness and Psychosocial Functioning in Adults with Prader-Willi Syndrome.

Prader–Willi syndrome autism autism spectrum disorders function functionality social function social responsiveness

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
05 Mar 2022
Historique:
received: 23 01 2022
revised: 20 02 2022
accepted: 02 03 2022
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 11 3 2022
Statut: epublish

Résumé

Although various studies have investigated symptoms of autism spectrum disorder (ASD) in Prader−Willi syndrome (PWS), little is known about the consequences of these symptoms, especially in psychosocial function. We aimed to explore ASD symptoms in adults with PWS with special attention to psychosocial functionality. This cross-sectional study included 26 adults (15 women) with PWS who attended a reference unit for rare diseases. Participants’ primary caregivers completed the Social Responsiveness Scale (SRS), and clinicians assessed multidimensional functioning with the Personal and Social Performance Scale (PSP). Impaired social responsiveness was identified in 20 (76.9%) participants, and manifest to marked difficulties in social functioning were identified in 13 (50%). Participants with impaired social responsiveness (SRS ≥ 60) had significantly worse scores in functionality measured with the PSP (U = 12.5; p = 0.009) and with three of the four PSP main areas. Moreover, scores for the Social Cognition domain of the SRS correlated positively with the Socially useful activities (p < 0.05) and Personal and social relationships (p < 0.01) main areas of the PSP. These results suggest that difficulties in social skills should be assessed in all psychosocial evaluations of patients with PWS.

Identifiants

pubmed: 35268524
pii: jcm11051433
doi: 10.3390/jcm11051433
pmc: PMC8911114
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Fondo de Investigación Sanitaria del Instituto Carlos III and Fondo Europeo de Desarrollo Regional
ID : PI-18/0734

Références

J Autism Dev Disord. 2019 Jun;49(6):2597-2604
pubmed: 30945091
MMWR Surveill Summ. 2014 Mar 28;63(2):1-21
pubmed: 24670961
Am J Med Genet A. 2015 Dec;167A(12):2936-44
pubmed: 26331980
Acta Psychiatr Scand. 2000 Apr;101(4):323-9
pubmed: 10782554
J Clin Med. 2021 May 07;10(9):
pubmed: 34067179
J Autism Dev Disord. 2018 Dec;48(12):3995-4006
pubmed: 29705922
Eur Neuropsychopharmacol. 2007 Feb;17(3):157-64
pubmed: 17079119
Eur Eat Disord Rev. 2020 Jul;28(4):433-444
pubmed: 32243021
J Neurodev Disord. 2017 Jun 5;9:18
pubmed: 28592997
Trends Cogn Sci. 2002 Jun 1;6(6):248-254
pubmed: 12039606
J Autism Dev Disord. 2006 Oct;36(7):949-57
pubmed: 16897399
J Autism Dev Disord. 2013 Jan;43(1):103-13
pubmed: 22576167
Front Pediatr. 2018 May 03;6:102
pubmed: 29774207
Curr Pediatr Rev. 2016;12(2):136-66
pubmed: 26592417
CNS Drugs. 2018 Aug;32(8):713-734
pubmed: 30105528
Psychiatr Genet. 2005 Dec;15(4):243-54
pubmed: 16314754
J Autism Dev Disord. 2003 Aug;33(4):427-33
pubmed: 12959421
J Child Psychol Psychiatry. 2008 Sep;49(9):1001-8
pubmed: 18665884
J Am Acad Child Adolesc Psychiatry. 2017 Jun;56(6):466-474
pubmed: 28545751
Autism. 2014 Jan;18(1):31-44
pubmed: 24019124
Autism Res. 2008 Dec;1(6):354-63
pubmed: 19360690
Mol Autism. 2020 Sep 29;11(1):73
pubmed: 32993801
Actas Esp Psiquiatr. 2019 May;47(3):79-87
pubmed: 31233206
Mol Psychiatry. 2006 Jan;11(1):1, 18-28
pubmed: 16205736
J Neurodev Disord. 2018 Aug 6;10(1):24
pubmed: 30081815
Autism Res. 2012 Jun;5(3):180-9
pubmed: 22581514
Hum Mol Genet. 2006 Oct 15;15 Spec No 2:R138-50
pubmed: 16987877
Soc Sci Med. 2020 Mar;248:112826
pubmed: 32036269
Rev Psiquiatr Salud Ment. 2011 Jan;4(1):9-18
pubmed: 23446097
Autism Res. 2017 Oct;10(10):1663-1671
pubmed: 28639377
Behav Neurol. 2017;2017:4615451
pubmed: 29440778
Biol Psychiatry. 2005 Mar 15;57(6):655-60
pubmed: 15780853
Am J Med Genet A. 2015 Jan;167A(1):64-8
pubmed: 25388910
Endocrinol Diabetes Nutr (Engl Ed). 2019 Nov;66(9):579-587
pubmed: 31006652
JAMA Psychiatry. 2014 Aug;71(8):936-42
pubmed: 25100167
Genet Med. 2012 Jan;14(1):10-26
pubmed: 22237428
Med Clin (Barc). 2021 Oct 22;:
pubmed: 34696903
Nat Rev Neurol. 2016 Oct;12(10):584-93
pubmed: 27615419
J Autism Dev Disord. 2017 Aug;47(8):2519-2534
pubmed: 28527095
Curr Psychiatry Rep. 2019 Mar 9;21(4):22
pubmed: 30852705
Curr Opin Psychiatry. 2011 Sep;24(5):367-71
pubmed: 21150621
J Am Acad Child Adolesc Psychiatry. 2007 Dec;46(12):1668-76
pubmed: 18030089

Auteurs

Meritxell Fernández-Lafitte (M)

Mental Health Department, Corporació Sanitària Parc Taulí-CIBERSAM, 08208 Sabadell, Barcelona, Spain.

Jesus Cobo (J)

Mental Health Department, Corporació Sanitària Parc Taulí-CIBERSAM, 08208 Sabadell, Barcelona, Spain.
Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.
Institut d'Investigació i Innovació Parc Taulí (I3PT), Centres de Recerca de Catalunya (CERCA), 08208 Sabadell, Barcelona, Spain.

Ramon Coronas (R)

Mental Health Department, Corporació Sanitària Parc Taulí-CIBERSAM, 08208 Sabadell, Barcelona, Spain.

Isabel Parra (I)

Mental Health Department, Corporació Sanitària Parc Taulí-CIBERSAM, 08208 Sabadell, Barcelona, Spain.
Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.
Institut d'Investigació i Innovació Parc Taulí (I3PT), Centres de Recerca de Catalunya (CERCA), 08208 Sabadell, Barcelona, Spain.

Joan Carles Oliva (JC)

Statistics Unit, Fundació Parc Taulí I3PT, CERCA, 08208 Sabadell, Barcelona, Spain.

Aida Àlvarez (A)

Autism Disorder and Severe Mental Illness Unit, Department of Mental Health, Mutua Terrassa University Hospital, 08221 Terrassa, Barcelona, Spain.

Susanna Esteba-Castillo (S)

Specialized Mental Health and Intellectual Disability Department, Institut Assistència Sanitària, Parc Hospitalari Martí i Julià, 17190 Salt, Girona, Spain.
Neurodevelopment Group, Girona Biomedical Research Institute "Dr. Josep Trueta" (IDIBGI), Institut Assistència Sanitària, Parc Hospitalari Martí i Julià, 17190 Salt, Girona, Spain.

Olga Giménez-Palop (O)

Endocrinology and Nutrition Department, Corporació Sanitària Parc Taulí, 8208 Sabadell, Barcelona, Spain.
Department of Medicine, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.

Diego J Palao (DJ)

Mental Health Department, Corporació Sanitària Parc Taulí-CIBERSAM, 08208 Sabadell, Barcelona, Spain.
Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.
Institut d'Investigació i Innovació Parc Taulí (I3PT), Centres de Recerca de Catalunya (CERCA), 08208 Sabadell, Barcelona, Spain.

Assumpta Caixàs (A)

Endocrinology and Nutrition Department, Corporació Sanitària Parc Taulí, 8208 Sabadell, Barcelona, Spain.
Department of Medicine, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.

Classifications MeSH